Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Endocrine-Related Cancer
|
March 23, 2023
Diffuse sclerosing variant papillary thyroid carcinoma has worse survival than classic papillary thyroid carcinoma: a meta-analysis
Henry Crayton, Katherine Wu, David Leong, et al.
Thyroid : Official Journal of the American Thyroid Association
|
June 28, 2024
The Association between Lymphocytic Thyroiditis and Papillary Thyroid Cancer Harboring Mutant <i>BRAF</i>: A Systematic Review and Meta-Analysis
Sumathy Perampalam, Katherine Wu, Matti Gild, et al.
Endocrine-Related Cancer
|
August 19, 2020
Thyroid cancer in the age of COVID-19
Venessa H M Tsang, Matti Gild, Anthony Glover, et al.
The Clinical Teacher
|
July 18, 2025
Variation in Students' Experiences and Approaches to Learning During Early Clinical Immersion
Naomi Staples, James Collett, Matti Gild, et al.
The Clinical Teacher
|
February 4, 2026
Personalised Pathways (PP) in the Medical Curriculum: How Does It Influence Students?
Annette Burgess, Naomi Staples, Matti Gild, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 1, 2022
Selpercatinib Treatment of RET-Mutated Thyroid Cancers Is Associated With Gastrointestinal Adverse Effects
Venessa Tsang, Anthony Gill, Matti Gild, et al.
Journal of the Endocrine Society
|
March 10, 2023
Thyroid Hormone Abuse Among Elite Athletes
David J Handelsman, Matti Gild, Roderick Clifton-Bligh, et al.
Endocrine-Related Cancer
|
November 27, 2024
Evaluating the prognostic potential of circulating cell-free DNA in advanced thyroid cancer
Ayanthi Wijewardene, Roderick J Clifton-Bligh, Bin Wang, et al.
Plos One
|
February 2, 2013
Genetic and pharmacological targeting of CSF-1/CSF-1R inhibits tumor-associated macrophages and impairs BRAF-induced thyroid cancer progression
Mabel Ryder, Matti Gild, Tobias M Hohl, et al.
Thyroid : Official Journal of the American Thyroid Association
|
November 23, 2022
A Case Report of Poor Response to Selpercatinib in the Presence of a 632_633 RET Deletion
Ayanthi Wijewardene, Karine Bastard, Bin Wang, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Endocrine-Related Cancer
|
March 23, 2023
Diffuse sclerosing variant papillary thyroid carcinoma has worse survival than classic papillary thyroid carcinoma: a meta-analysis
Henry Crayton, Katherine Wu, David Leong, et al.
Thyroid : Official Journal of the American Thyroid Association
|
June 28, 2024
The Association between Lymphocytic Thyroiditis and Papillary Thyroid Cancer Harboring Mutant <i>BRAF</i>: A Systematic Review and Meta-Analysis
Sumathy Perampalam, Katherine Wu, Matti Gild, et al.
Endocrine-Related Cancer
|
August 19, 2020
Thyroid cancer in the age of COVID-19
Venessa H M Tsang, Matti Gild, Anthony Glover, et al.
The Clinical Teacher
|
July 18, 2025
Variation in Students' Experiences and Approaches to Learning During Early Clinical Immersion
Naomi Staples, James Collett, Matti Gild, et al.
The Clinical Teacher
|
February 4, 2026
Personalised Pathways (PP) in the Medical Curriculum: How Does It Influence Students?
Annette Burgess, Naomi Staples, Matti Gild, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 1, 2022
Selpercatinib Treatment of RET-Mutated Thyroid Cancers Is Associated With Gastrointestinal Adverse Effects
Venessa Tsang, Anthony Gill, Matti Gild, et al.
Journal of the Endocrine Society
|
March 10, 2023
Thyroid Hormone Abuse Among Elite Athletes
David J Handelsman, Matti Gild, Roderick Clifton-Bligh, et al.
Endocrine-Related Cancer
|
November 27, 2024
Evaluating the prognostic potential of circulating cell-free DNA in advanced thyroid cancer
Ayanthi Wijewardene, Roderick J Clifton-Bligh, Bin Wang, et al.
Plos One
|
February 2, 2013
Genetic and pharmacological targeting of CSF-1/CSF-1R inhibits tumor-associated macrophages and impairs BRAF-induced thyroid cancer progression
Mabel Ryder, Matti Gild, Tobias M Hohl, et al.
Thyroid : Official Journal of the American Thyroid Association
|
November 23, 2022
A Case Report of Poor Response to Selpercatinib in the Presence of a 632_633 RET Deletion
Ayanthi Wijewardene, Karine Bastard, Bin Wang, et al.
Page
of 2